Archived 24: National Advisory Committee on Immunization (NACI) statement: Recommendation on the use of the Pfizer-BioNTech COVID-19 vaccine (10 mcg) in children 5 to 11 years of age [2021-11-19]

Resumen documental de ASEM

Official National Advisory Committee on Immunization document (2021) on “Archived 24: National Advisory Committee on Immunization (NACI) statement: Recommendation on the use of the Pfizer-BioNTech COVID-19 vaccine (10 mcg) in children 5 to 11 years of age [2021-11-19]”. NACI recommendations on the use of the Pfizer-BioNTech COVID-19 vaccine in children 5 to 11 years of age: Background, methods, summary of evidence, research priorities, acknowledgments, abbreviations and frequency of solicited adverse events following immunization for COVID-19 in clinical trials.

Este resumen facilita la identificación del documento. Para consultar recomendaciones clínicas, consulte siempre la versión oficial vigente y su fecha de actualización.